`
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`EDWARDS LIFESCIENCES CORPORATION,
`
`
`
`Petitioner,
`
`v.
`
`ENDOHEART AG,
`
`Patent Owner.
`
`____________
`
`Case IPR2016-00299
`
`U.S. Patent No. 8,182,530
`
`____________
`
`JOINT MOTION OF PETITIONER AND PATENT OWNER
`TO TERMINATE PROCEEDING
`PURSUANT TO 35 U.S.C. § 317 AND 37 C.F.R. § 42.74
`
`
`
`Joint Motion to Terminate Proceeding
`Case IPR2016-00299
`U.S. Patent No. 8,182,530
`
`
`STATEMENT OF PRECISE RELIEF REQUESTED
`
`Pursuant to 35 U.S.C. § 317, 37 C.F.R. § 42.74, and the Board’s
`
`authorization provided on June 9, 2016, Petitioner EDWARDS LIFESCIENCES
`
`CORPORATION (“Petitioner” or “Edwards”) and Patent Owner ENDOHEART
`
`AG (“Patent Owner” or “Endoheart”) (collectively the “Parties”) jointly request
`
`termination of Inter Partes Review No. IPR2016-00299, which is directed to U.S.
`
`Patent No. 8,182,530 (the “‘530 Patent”), pursuant to settlement. As there are no
`
`other petitioners in this proceeding and the proceeding is still pre-trial, the Parties
`
`respectfully submit that termination of this proceeding is appropriate.
`
`STATEMENT OF FACTS
`
`Petitioner filed their petition in this proceeding for Inter Partes Review of
`
`the ‘530 Patent on December 9, 2015. In turn, Patent Owner filed a Preliminary
`
`Response on March 15, 2016. Petitioner also filed another petition for Inter Partes
`
`review of the ‘530 Patent in IPR2016-00300 on December 9, 2015. No other
`
`petitions related to the ‘530 Patent are pending.
`
`The deadline for entering a decision regarding institution by the Board is
`
`June 15, 2016. Petitioner and Patent Owner have reached a Settlement Agreement
`
`to end their disputes in this proceeding and the related litigation. Pursuant to 35
`
`U.S.C. § 317(b) and 37 CFR § 42.74(b), the agreement between the Parties is in
`
`
`
`
`
`2
`
`
`
`writing, constitutes the entire understanding and agreement between the Parties,
`
`Joint Motion to Terminate Proceeding
`Case IPR2016-00299
`U.S. Patent No. 8,182,530
`
`
`and a copy of the Settlement Agreement is submitted herewith as Exhibit 1046.
`
`The Parties jointly request that the Settlement Agreement be treated as business
`
`confidential information and kept separate from the underlying patent file, as
`
`provided in 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c), to maintain
`
`confidentiality of the Settlement Agreement. A separate joint request to that effect
`
`is being filed concurrently herewith.
`
`ARGUMENT
`
`A joint motion to terminate generally “must (1) include a brief explanation
`
`as to why termination is appropriate; (2) identify all parties in any related litigation
`
`involving the patents at issue; (3) identify any related proceedings currently before
`
`the Office, and (4) discuss specifically the current status of each such related
`
`litigation or proceeding with respect to each party to the litigation or proceeding.”
`
`Heartland Tanning, Inc. v. Sunless, Inc., IPR2014-00018, Paper 26 at 2 (PTAB Jul.
`
`28, 2014).
`
`The Board should terminate this case as the Parties jointly request, for the
`
`following reasons.
`
`
`
`3
`
`
`
`
`
`
`
`Joint Motion to Terminate Proceeding
`Case IPR2016-00299
`U.S. Patent No. 8,182,530
`
`
`1. Brief Explanation As To Why Termination is Appropriate
`
`The Parties have met the statutory requirement that they file a “joint request”
`
`to terminate before the Office “has decided the merits of the proceeding.” 35
`
`U.S.C. § 317(a). The proceeding is still at an early stage (pre-trial). No decision
`
`regarding institution has been entered by the Board. Further, no prior motions are
`
`pending in this proceeding.
`
`The Parties have reached a settlement as to the ‘530 Patent to end this
`
`dispute. A copy of the confidential Settlement Agreement pertaining to
`
`this case is filed concurrently herewith. See Ex. 1046. The Parties jointly certify
`
`that there is no other agreement or understanding between them, including any
`
`collateral agreement, made in connection with, or in contemplation of, the
`
`termination of the instant proceeding as set forth in 35 U.S.C. § 317(b).
`
`The Parties respectfully submit that termination of this proceeding is
`
`appropriate because
`
`(a) this proceeding is at an early stage (pre-trial) and no motions are
`
`outstanding;
`
`(b) the Parties have reached agreement to end their dispute concerning
`
`the ‘530 Patent;
`
`(c) the Parties have agreed to dismiss the related district court
`
`
`
`
`
`4
`
`
`
`Joint Motion to Terminate Proceeding
`Case IPR2016-00299
`U.S. Patent No. 8,182,530
`
`
`litigation with respect to the ‘530 Patent;
`
`(d) the Parties agree that this Inter Partes Review should be
`
`terminated; and
`
`(e) termination of this proceeding will preserve the Board’s resources
`
`and obviate the need for any more Board involvement in this matter.
`
`
`
`2. Identity and Status of Parties in Related Litigation Involving the Patent
`
`The ‘530 Patent is in dispute in Endoheart AG v. Edwards Lifesciences
`
`Corporation, Case No. 1:14-cv-01473 (D. Del.). The Parties have agreed to
`
`dismiss this litigation.
`
`
`3. Identity and Status of Any Related Proceedings Before the Office
`
`Petitioner filed another petition for Inter Partes Review of the ‘530 Patent in
`
`IPR2016-00300 on December 9, 2015. In turn, Patent Owner filed a Preliminary
`
`Response on March 15, 2016. No decision regarding institution has been entered
`
`by the Board. Petitioner is concurrently filing a Joint Motion to Terminate the
`
`Proceeding in IPR2016-00300.
`
`No other proceedings related to the ‘530 Patent are pending.
`
`
`
`
`
`
`
`5
`
`
`
`Joint Motion to Terminate Proceeding
`Case IPR2016-00299
`U.S. Patent No. 8,182,530
`
`
`CONCLUSION
`
`For at least the foregoing reasons, Petitioner and Patent Owner respectfully
`
`request termination of this Inter Partes Review.
`
`
`
`
`
`
`
`
`
`Dated: June 10, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/W. Todd Baker/
`W. Todd Baker
`Reg. No. 45,265
`OBLON
`1940 Duke Street
`Alexandria, VA 22314
`Attorney for Petitioner
`Edwards Lifesciences Corporation
`
`/Edward M. Arons/
`Edward M. Arons
`Reg. No. 44,511
`Weiss & Arons, LLP
`1540 Route 202
`Pomona, New York 10977
`Attorney for Patent Owner
`Endoheart AG
`
`
`
`
`
`6
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies service of the
`
`JOINT MOTION TO TERMINATE PROCEEDING along with EXHIBIT 1046
`
`on the counsel of record for the Patent Owner by filing this document through the
`
`Patent Review Processing System as well as delivering a copy via electronic mail
`
`to the following addresses:
`
`Edward M. Arons
`earons@weissarons.com
`
`Joel Weiss
`jweiss@weissarons.com
`Endoheart-IPR@weissarons.com
`
`Dated: June 10, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/W. Todd Baker/
`W. Todd Baker
`Reg. No. 45,265